Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
March 5, 2026 | White Papers and Resources |
At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more …
Brought to you by Inizio
March 5, 2026 | White Papers and Resources |
Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more …
Brought to you by Inizio
March 5, 2026 | White Papers and Resources |
Securing your exhibition space is a significant milestone. The contract is signed, the floorplan is confirmed and the event is in the calendar. So what …
Brought to you by Apex Events and Exhibitions
March 2, 2026 | White Papers and Resources |
Rare disease launches are complex by nature. Yet one of the most consistent risks we see is rarely treated as a launch issue at all: …
Brought to you by Havas Life London
February 27, 2026 | White Papers and Resources |
By Sarah Mohamad
Brought to you by Amiculum
February 23, 2026 | White Papers and Resources |
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients’ lives to …
Brought to you by Cuttsy + Cuttsy
February 17, 2026 | White Papers and Resources |
By Zoë van Helmond
Brought to you by Amiculum
February 17, 2026 | White Papers and Resources |
By Betty Charleshouse
Brought to you by Amiculum
February 16, 2026 | White Papers and Resources |
We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the …
Brought to you by Graphite Digital
January 19, 2026 | White Papers and Resources |
Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines …
Brought to you by Amiculum